nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—Labetalol—hypertension	0.291	1	CrCtD
Formoterol—ADRB1—hypertension	0.0713	0.543	CbGaD
Formoterol—ADRB2—hypertension	0.06	0.457	CbGaD
Formoterol—Arformoterol—Labetalol—hypertension	0.0319	0.162	CrCrCtD
Formoterol—Dobutamine—Labetalol—hypertension	0.0287	0.146	CrCrCtD
Formoterol—Fenoterol—Labetalol—hypertension	0.0222	0.113	CrCrCtD
Formoterol—Ritodrine—Labetalol—hypertension	0.0222	0.113	CrCrCtD
Formoterol—Arbutamine—Labetalol—hypertension	0.0195	0.099	CrCrCtD
Formoterol—Isoprenaline—Methyldopa—hypertension	0.0166	0.0843	CrCrCtD
Formoterol—Isoprenaline—Pindolol—hypertension	0.0144	0.0734	CrCrCtD
Formoterol—Labetalol—Quinapril—hypertension	0.0142	0.0725	CrCrCtD
Formoterol—Labetalol—Benazepril—hypertension	0.0139	0.0708	CrCrCtD
Formoterol—Isoprenaline—Labetalol—hypertension	0.0128	0.065	CrCrCtD
Formoterol—ADRB2—Esmolol—hypertension	0.0123	0.0469	CbGbCtD
Formoterol—ADRB1—Esmolol—hypertension	0.0121	0.0462	CbGbCtD
Formoterol—ADRB2—Labetalol—hypertension	0.00935	0.0356	CbGbCtD
Formoterol—ADRB2—Nebivolol—hypertension	0.00935	0.0356	CbGbCtD
Formoterol—ADRB2—Nadolol—hypertension	0.00935	0.0356	CbGbCtD
Formoterol—ADRB1—Nebivolol—hypertension	0.00921	0.035	CbGbCtD
Formoterol—ADRB1—Labetalol—hypertension	0.00921	0.035	CbGbCtD
Formoterol—ADRB1—Nadolol—hypertension	0.00921	0.035	CbGbCtD
Formoterol—ADRB2—Acebutolol—hypertension	0.00855	0.0325	CbGbCtD
Formoterol—ADRB1—Acebutolol—hypertension	0.00842	0.032	CbGbCtD
Formoterol—ADRB2—Pindolol—hypertension	0.00795	0.0302	CbGbCtD
Formoterol—ADRB2—Metoprolol—hypertension	0.00795	0.0302	CbGbCtD
Formoterol—ADRB1—Pindolol—hypertension	0.00783	0.0298	CbGbCtD
Formoterol—ADRB1—Metoprolol—hypertension	0.00783	0.0298	CbGbCtD
Formoterol—ADRB2—Betaxolol—hypertension	0.00708	0.0269	CbGbCtD
Formoterol—ADRB1—Betaxolol—hypertension	0.00698	0.0265	CbGbCtD
Formoterol—ADRB2—Penbutolol—hypertension	0.00648	0.0246	CbGbCtD
Formoterol—ADRB1—Penbutolol—hypertension	0.00638	0.0243	CbGbCtD
Formoterol—ADRB2—Timolol—hypertension	0.00456	0.0174	CbGbCtD
Formoterol—ADRB1—Timolol—hypertension	0.0045	0.0171	CbGbCtD
Formoterol—ADRB2—Carvedilol—hypertension	0.00442	0.0168	CbGbCtD
Formoterol—ADRB1—Carvedilol—hypertension	0.00435	0.0166	CbGbCtD
Formoterol—ADRB2—Propranolol—hypertension	0.00407	0.0155	CbGbCtD
Formoterol—ADRB1—Propranolol—hypertension	0.00401	0.0152	CbGbCtD
Formoterol—CYP2A6—Amlodipine—hypertension	0.00384	0.0146	CbGbCtD
Formoterol—CYP2A6—Nifedipine—hypertension	0.00358	0.0136	CbGbCtD
Formoterol—CYP2C9—Eprosartan—hypertension	0.00288	0.0109	CbGbCtD
Formoterol—CYP2C19—Torasemide—hypertension	0.00282	0.0107	CbGbCtD
Formoterol—CYP2C19—Guanfacine—hypertension	0.00262	0.00997	CbGbCtD
Formoterol—CYP2C19—Metoprolol—hypertension	0.00262	0.00997	CbGbCtD
Formoterol—CYP2C9—Torasemide—hypertension	0.00234	0.00892	CbGbCtD
Formoterol—CYP2D6—Nebivolol—hypertension	0.00234	0.00892	CbGbCtD
Formoterol—CYP2D6—Labetalol—hypertension	0.00234	0.00892	CbGbCtD
Formoterol—CYP2C9—Candesartan—hypertension	0.00218	0.00829	CbGbCtD
Formoterol—CYP2C9—Guanfacine—hypertension	0.00218	0.00829	CbGbCtD
Formoterol—CYP2D6—Acebutolol—hypertension	0.00214	0.00816	CbGbCtD
Formoterol—CYP2C19—Doxazosin—hypertension	0.00206	0.00783	CbGbCtD
Formoterol—CYP2D6—Metoprolol—hypertension	0.00199	0.00758	CbGbCtD
Formoterol—CYP2D6—Pindolol—hypertension	0.00199	0.00758	CbGbCtD
Formoterol—CYP2C19—Diltiazem—hypertension	0.00199	0.00756	CbGbCtD
Formoterol—CYP2C19—Telmisartan—hypertension	0.00187	0.00711	CbGbCtD
Formoterol—CYP2D6—Betaxolol—hypertension	0.00178	0.00676	CbGbCtD
Formoterol—CYP2C9—Diltiazem—hypertension	0.00165	0.00628	CbGbCtD
Formoterol—CYP2D6—Doxazosin—hypertension	0.00156	0.00595	CbGbCtD
Formoterol—CYP2C9—Valsartan—hypertension	0.00151	0.00575	CbGbCtD
Formoterol—CYP2D6—Diltiazem—hypertension	0.00151	0.00575	CbGbCtD
Formoterol—CYP2C19—Timolol—hypertension	0.00151	0.00573	CbGbCtD
Formoterol—CYP2C19—Nicardipine—hypertension	0.00146	0.00555	CbGbCtD
Formoterol—CYP2C9—Irbesartan—hypertension	0.00135	0.00512	CbGbCtD
Formoterol—CYP2D6—Bepridil—hypertension	0.00135	0.00512	CbGbCtD
Formoterol—CYP2C19—Propranolol—hypertension	0.00134	0.00511	CbGbCtD
Formoterol—CYP2C9—Amlodipine—hypertension	0.00132	0.00502	CbGbCtD
Formoterol—CYP2C9—Felodipine—hypertension	0.00127	0.00484	CbGbCtD
Formoterol—CYP2C9—Nifedipine—hypertension	0.00123	0.00469	CbGbCtD
Formoterol—CYP2D6—Irbesartan—hypertension	0.00123	0.00468	CbGbCtD
Formoterol—CYP2C9—Carvedilol—hypertension	0.00121	0.00461	CbGbCtD
Formoterol—CYP2C9—Nicardipine—hypertension	0.00121	0.00461	CbGbCtD
Formoterol—CYP2D6—Amlodipine—hypertension	0.00121	0.00459	CbGbCtD
Formoterol—CYP2D6—Felodipine—hypertension	0.00116	0.00443	CbGbCtD
Formoterol—CYP2D6—Timolol—hypertension	0.00114	0.00435	CbGbCtD
Formoterol—CYP2C19—Atorvastatin—hypertension	0.00114	0.00434	CbGbCtD
Formoterol—CYP2D6—Nifedipine—hypertension	0.00113	0.00428	CbGbCtD
Formoterol—CYP2D6—Carvedilol—hypertension	0.00111	0.00422	CbGbCtD
Formoterol—CYP2D6—Nicardipine—hypertension	0.00111	0.00422	CbGbCtD
Formoterol—CYP2C19—Losartan—hypertension	0.00104	0.00397	CbGbCtD
Formoterol—CYP2D6—Propranolol—hypertension	0.00102	0.00388	CbGbCtD
Formoterol—CYP2D6—Captopril—hypertension	0.00101	0.00383	CbGbCtD
Formoterol—CYP2D6—Clonidine—hypertension	0.000973	0.0037	CbGbCtD
Formoterol—CYP2C9—Atorvastatin—hypertension	0.000949	0.00361	CbGbCtD
Formoterol—CYP2C19—Verapamil—hypertension	0.000921	0.0035	CbGbCtD
Formoterol—CYP2C9—Losartan—hypertension	0.000868	0.0033	CbGbCtD
Formoterol—CYP2D6—Atorvastatin—hypertension	0.000868	0.0033	CbGbCtD
Formoterol—CYP2C9—Verapamil—hypertension	0.000766	0.00291	CbGbCtD
Formoterol—CYP2D6—Verapamil—hypertension	0.0007	0.00266	CbGbCtD
Formoterol—ADRB2—Treprostinil—Nadolol—hypertension	0.000517	1	CbGdCrCtD
Formoterol—Isoprenaline—PIK3R1—hypertension	0.000296	0.18	CrCbGaD
Formoterol—Isoprenaline—ADRBK1—hypertension	0.000214	0.13	CrCbGaD
Formoterol—Dobutamine—COMT—hypertension	0.000134	0.0813	CrCbGaD
Formoterol—Fenoterol—ADRB1—hypertension	9.89e-05	0.0601	CrCbGaD
Formoterol—Arbutamine—ADRB1—hypertension	9.25e-05	0.0562	CrCbGaD
Formoterol—Arformoterol—ADRB1—hypertension	8.98e-05	0.0546	CrCbGaD
Formoterol—Dobutamine—ADRB1—hypertension	8.52e-05	0.0517	CrCbGaD
Formoterol—Fenoterol—ADRB2—hypertension	8.32e-05	0.0506	CrCbGaD
Formoterol—Ritodrine—ADRB2—hypertension	8.32e-05	0.0506	CrCbGaD
Formoterol—Arbutamine—ADRB2—hypertension	7.78e-05	0.0473	CrCbGaD
Formoterol—Arformoterol—ADRB2—hypertension	7.55e-05	0.0459	CrCbGaD
Formoterol—Dobutamine—ADRB2—hypertension	7.16e-05	0.0435	CrCbGaD
Formoterol—Labetalol—ADRB1—hypertension	6.56e-05	0.0399	CrCbGaD
Formoterol—Labetalol—ADRB2—hypertension	5.52e-05	0.0335	CrCbGaD
Formoterol—Isoprenaline—ADRB1—hypertension	4.83e-05	0.0294	CrCbGaD
Formoterol—Isoprenaline—ADRB2—hypertension	4.06e-05	0.0247	CrCbGaD
Formoterol—Isoprenaline—CYP1A1—hypertension	3.48e-05	0.0212	CrCbGaD
Formoterol—Diarrhoea—Valsartan—hypertension	9.49e-06	0.000118	CcSEcCtD
Formoterol—Asthenia—Clonidine—hypertension	9.48e-06	0.000118	CcSEcCtD
Formoterol—Feeling abnormal—Betaxolol—hypertension	9.48e-06	0.000118	CcSEcCtD
Formoterol—Vomiting—Verapamil—hypertension	9.47e-06	0.000117	CcSEcCtD
Formoterol—Urticaria—Irbesartan—hypertension	9.47e-06	0.000117	CcSEcCtD
Formoterol—Hypersensitivity—Enalapril—hypertension	9.46e-06	0.000117	CcSEcCtD
Formoterol—Abdominal pain—Perindopril—hypertension	9.45e-06	0.000117	CcSEcCtD
Formoterol—Body temperature increased—Perindopril—hypertension	9.45e-06	0.000117	CcSEcCtD
Formoterol—Palpitations—Lisinopril—hypertension	9.44e-06	0.000117	CcSEcCtD
Formoterol—Diarrhoea—Olmesartan—hypertension	9.44e-06	0.000117	CcSEcCtD
Formoterol—Headache—Eplerenone—hypertension	9.44e-06	0.000117	CcSEcCtD
Formoterol—Rash—Nifedipine—hypertension	9.43e-06	0.000117	CcSEcCtD
Formoterol—Nervous system disorder—Ramipril—hypertension	9.43e-06	0.000117	CcSEcCtD
Formoterol—Dermatitis—Nifedipine—hypertension	9.42e-06	0.000117	CcSEcCtD
Formoterol—Abdominal pain—Irbesartan—hypertension	9.42e-06	0.000117	CcSEcCtD
Formoterol—Body temperature increased—Irbesartan—hypertension	9.42e-06	0.000117	CcSEcCtD
Formoterol—Oedema—Timolol—hypertension	9.4e-06	0.000117	CcSEcCtD
Formoterol—Anaphylactic shock—Timolol—hypertension	9.4e-06	0.000117	CcSEcCtD
Formoterol—Rash—Verapamil—hypertension	9.39e-06	0.000117	CcSEcCtD
Formoterol—Urticaria—Hydrochlorothiazide—hypertension	9.39e-06	0.000116	CcSEcCtD
Formoterol—Tachycardia—Ramipril—hypertension	9.39e-06	0.000116	CcSEcCtD
Formoterol—Dermatitis—Verapamil—hypertension	9.38e-06	0.000116	CcSEcCtD
Formoterol—Headache—Nifedipine—hypertension	9.37e-06	0.000116	CcSEcCtD
Formoterol—Pruritus—Clonidine—hypertension	9.35e-06	0.000116	CcSEcCtD
Formoterol—Abdominal pain—Hydrochlorothiazide—hypertension	9.34e-06	0.000116	CcSEcCtD
Formoterol—Body temperature increased—Hydrochlorothiazide—hypertension	9.34e-06	0.000116	CcSEcCtD
Formoterol—Skin disorder—Ramipril—hypertension	9.34e-06	0.000116	CcSEcCtD
Formoterol—Infection—Timolol—hypertension	9.34e-06	0.000116	CcSEcCtD
Formoterol—Headache—Verapamil—hypertension	9.33e-06	0.000116	CcSEcCtD
Formoterol—Hypersensitivity—Telmisartan—hypertension	9.33e-06	0.000116	CcSEcCtD
Formoterol—Cough—Lisinopril—hypertension	9.33e-06	0.000116	CcSEcCtD
Formoterol—Nausea—Diltiazem—hypertension	9.31e-06	0.000116	CcSEcCtD
Formoterol—Nausea—Indapamide—hypertension	9.31e-06	0.000116	CcSEcCtD
Formoterol—Asthenia—Trandolapril—hypertension	9.25e-06	0.000115	CcSEcCtD
Formoterol—Feeling abnormal—Losartan—hypertension	9.24e-06	0.000115	CcSEcCtD
Formoterol—Urticaria—Furosemide—hypertension	9.23e-06	0.000115	CcSEcCtD
Formoterol—Nervous system disorder—Timolol—hypertension	9.22e-06	0.000114	CcSEcCtD
Formoterol—Nausea—Carvedilol—hypertension	9.22e-06	0.000114	CcSEcCtD
Formoterol—Asthenia—Enalapril—hypertension	9.21e-06	0.000114	CcSEcCtD
Formoterol—Body temperature increased—Furosemide—hypertension	9.19e-06	0.000114	CcSEcCtD
Formoterol—Abdominal pain—Furosemide—hypertension	9.19e-06	0.000114	CcSEcCtD
Formoterol—Gastrointestinal pain—Losartan—hypertension	9.17e-06	0.000114	CcSEcCtD
Formoterol—Dizziness—Valsartan—hypertension	9.17e-06	0.000114	CcSEcCtD
Formoterol—Urticaria—Betaxolol—hypertension	9.14e-06	0.000113	CcSEcCtD
Formoterol—Skin disorder—Timolol—hypertension	9.13e-06	0.000113	CcSEcCtD
Formoterol—Dizziness—Olmesartan—hypertension	9.13e-06	0.000113	CcSEcCtD
Formoterol—Pruritus—Trandolapril—hypertension	9.12e-06	0.000113	CcSEcCtD
Formoterol—Nausea—Doxazosin—hypertension	9.12e-06	0.000113	CcSEcCtD
Formoterol—Chest pain—Lisinopril—hypertension	9.1e-06	0.000113	CcSEcCtD
Formoterol—Arthralgia—Lisinopril—hypertension	9.1e-06	0.000113	CcSEcCtD
Formoterol—Myalgia—Lisinopril—hypertension	9.1e-06	0.000113	CcSEcCtD
Formoterol—Body temperature increased—Betaxolol—hypertension	9.1e-06	0.000113	CcSEcCtD
Formoterol—Asthenia—Telmisartan—hypertension	9.09e-06	0.000113	CcSEcCtD
Formoterol—Pruritus—Enalapril—hypertension	9.08e-06	0.000113	CcSEcCtD
Formoterol—Anxiety—Lisinopril—hypertension	9.07e-06	0.000112	CcSEcCtD
Formoterol—Diarrhoea—Clonidine—hypertension	9.04e-06	0.000112	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	9.04e-06	0.000112	CcSEcCtD
Formoterol—Nausea—Fosinopril—hypertension	9.01e-06	0.000112	CcSEcCtD
Formoterol—Discomfort—Lisinopril—hypertension	8.99e-06	0.000112	CcSEcCtD
Formoterol—Hypotension—Ramipril—hypertension	8.99e-06	0.000111	CcSEcCtD
Formoterol—Pruritus—Telmisartan—hypertension	8.96e-06	0.000111	CcSEcCtD
Formoterol—Nausea—Eplerenone—hypertension	8.95e-06	0.000111	CcSEcCtD
Formoterol—Urticaria—Losartan—hypertension	8.91e-06	0.000111	CcSEcCtD
Formoterol—Dry mouth—Lisinopril—hypertension	8.9e-06	0.00011	CcSEcCtD
Formoterol—Nausea—Nifedipine—hypertension	8.89e-06	0.00011	CcSEcCtD
Formoterol—Abdominal pain—Losartan—hypertension	8.87e-06	0.00011	CcSEcCtD
Formoterol—Body temperature increased—Losartan—hypertension	8.87e-06	0.00011	CcSEcCtD
Formoterol—Nausea—Verapamil—hypertension	8.85e-06	0.00011	CcSEcCtD
Formoterol—Asthenia—Captopril—hypertension	8.84e-06	0.00011	CcSEcCtD
Formoterol—Diarrhoea—Trandolapril—hypertension	8.82e-06	0.000109	CcSEcCtD
Formoterol—Vomiting—Valsartan—hypertension	8.82e-06	0.000109	CcSEcCtD
Formoterol—Diarrhoea—Enalapril—hypertension	8.79e-06	0.000109	CcSEcCtD
Formoterol—Hypotension—Timolol—hypertension	8.78e-06	0.000109	CcSEcCtD
Formoterol—Hypersensitivity—Irbesartan—hypertension	8.78e-06	0.000109	CcSEcCtD
Formoterol—Vomiting—Olmesartan—hypertension	8.77e-06	0.000109	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Ramipril—hypertension	8.76e-06	0.000109	CcSEcCtD
Formoterol—Rash—Valsartan—hypertension	8.74e-06	0.000108	CcSEcCtD
Formoterol—Dizziness—Clonidine—hypertension	8.74e-06	0.000108	CcSEcCtD
Formoterol—Dermatitis—Valsartan—hypertension	8.74e-06	0.000108	CcSEcCtD
Formoterol—Anaphylactic shock—Lisinopril—hypertension	8.72e-06	0.000108	CcSEcCtD
Formoterol—Oedema—Lisinopril—hypertension	8.72e-06	0.000108	CcSEcCtD
Formoterol—Pruritus—Captopril—hypertension	8.71e-06	0.000108	CcSEcCtD
Formoterol—Hypersensitivity—Hydrochlorothiazide—hypertension	8.71e-06	0.000108	CcSEcCtD
Formoterol—Rash—Olmesartan—hypertension	8.7e-06	0.000108	CcSEcCtD
Formoterol—Insomnia—Ramipril—hypertension	8.7e-06	0.000108	CcSEcCtD
Formoterol—Dermatitis—Olmesartan—hypertension	8.69e-06	0.000108	CcSEcCtD
Formoterol—Headache—Valsartan—hypertension	8.69e-06	0.000108	CcSEcCtD
Formoterol—Diarrhoea—Telmisartan—hypertension	8.67e-06	0.000108	CcSEcCtD
Formoterol—Infection—Lisinopril—hypertension	8.66e-06	0.000107	CcSEcCtD
Formoterol—Headache—Olmesartan—hypertension	8.65e-06	0.000107	CcSEcCtD
Formoterol—Asthenia—Perindopril—hypertension	8.58e-06	0.000106	CcSEcCtD
Formoterol—Dyspnoea—Ramipril—hypertension	8.57e-06	0.000106	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Timolol—hypertension	8.57e-06	0.000106	CcSEcCtD
Formoterol—Hypersensitivity—Furosemide—hypertension	8.56e-06	0.000106	CcSEcCtD
Formoterol—Asthenia—Irbesartan—hypertension	8.55e-06	0.000106	CcSEcCtD
Formoterol—Somnolence—Ramipril—hypertension	8.55e-06	0.000106	CcSEcCtD
Formoterol—Dizziness—Trandolapril—hypertension	8.53e-06	0.000106	CcSEcCtD
Formoterol—Tachycardia—Lisinopril—hypertension	8.51e-06	0.000106	CcSEcCtD
Formoterol—Insomnia—Timolol—hypertension	8.5e-06	0.000105	CcSEcCtD
Formoterol—Dizziness—Enalapril—hypertension	8.49e-06	0.000105	CcSEcCtD
Formoterol—Asthenia—Hydrochlorothiazide—hypertension	8.48e-06	0.000105	CcSEcCtD
Formoterol—Hypersensitivity—Betaxolol—hypertension	8.48e-06	0.000105	CcSEcCtD
Formoterol—Skin disorder—Lisinopril—hypertension	8.47e-06	0.000105	CcSEcCtD
Formoterol—Dyspepsia—Ramipril—hypertension	8.47e-06	0.000105	CcSEcCtD
Formoterol—Pruritus—Perindopril—hypertension	8.46e-06	0.000105	CcSEcCtD
Formoterol—Pruritus—Irbesartan—hypertension	8.43e-06	0.000105	CcSEcCtD
Formoterol—Diarrhoea—Captopril—hypertension	8.43e-06	0.000105	CcSEcCtD
Formoterol—Vomiting—Clonidine—hypertension	8.4e-06	0.000104	CcSEcCtD
Formoterol—Dyspnoea—Timolol—hypertension	8.38e-06	0.000104	CcSEcCtD
Formoterol—Dizziness—Telmisartan—hypertension	8.37e-06	0.000104	CcSEcCtD
Formoterol—Pruritus—Hydrochlorothiazide—hypertension	8.36e-06	0.000104	CcSEcCtD
Formoterol—Somnolence—Timolol—hypertension	8.36e-06	0.000104	CcSEcCtD
Formoterol—Asthenia—Furosemide—hypertension	8.34e-06	0.000103	CcSEcCtD
Formoterol—Rash—Clonidine—hypertension	8.33e-06	0.000103	CcSEcCtD
Formoterol—Dermatitis—Clonidine—hypertension	8.33e-06	0.000103	CcSEcCtD
Formoterol—Gastrointestinal disorder—Ramipril—hypertension	8.3e-06	0.000103	CcSEcCtD
Formoterol—Fatigue—Ramipril—hypertension	8.29e-06	0.000103	CcSEcCtD
Formoterol—Headache—Clonidine—hypertension	8.28e-06	0.000103	CcSEcCtD
Formoterol—Dyspepsia—Timolol—hypertension	8.28e-06	0.000103	CcSEcCtD
Formoterol—Hypersensitivity—Losartan—hypertension	8.26e-06	0.000103	CcSEcCtD
Formoterol—Asthenia—Betaxolol—hypertension	8.26e-06	0.000102	CcSEcCtD
Formoterol—Nausea—Valsartan—hypertension	8.24e-06	0.000102	CcSEcCtD
Formoterol—Pruritus—Furosemide—hypertension	8.22e-06	0.000102	CcSEcCtD
Formoterol—Constipation—Ramipril—hypertension	8.22e-06	0.000102	CcSEcCtD
Formoterol—Nausea—Olmesartan—hypertension	8.2e-06	0.000102	CcSEcCtD
Formoterol—Vomiting—Trandolapril—hypertension	8.2e-06	0.000102	CcSEcCtD
Formoterol—Diarrhoea—Perindopril—hypertension	8.18e-06	0.000102	CcSEcCtD
Formoterol—Vomiting—Enalapril—hypertension	8.16e-06	0.000101	CcSEcCtD
Formoterol—Diarrhoea—Irbesartan—hypertension	8.15e-06	0.000101	CcSEcCtD
Formoterol—Hypotension—Lisinopril—hypertension	8.15e-06	0.000101	CcSEcCtD
Formoterol—Dizziness—Captopril—hypertension	8.14e-06	0.000101	CcSEcCtD
Formoterol—Pruritus—Betaxolol—hypertension	8.14e-06	0.000101	CcSEcCtD
Formoterol—Rash—Trandolapril—hypertension	8.13e-06	0.000101	CcSEcCtD
Formoterol—Dermatitis—Trandolapril—hypertension	8.12e-06	0.000101	CcSEcCtD
Formoterol—Gastrointestinal disorder—Timolol—hypertension	8.12e-06	0.000101	CcSEcCtD
Formoterol—Fatigue—Timolol—hypertension	8.11e-06	0.000101	CcSEcCtD
Formoterol—Rash—Enalapril—hypertension	8.1e-06	0.0001	CcSEcCtD
Formoterol—Dermatitis—Enalapril—hypertension	8.09e-06	0.0001	CcSEcCtD
Formoterol—Diarrhoea—Hydrochlorothiazide—hypertension	8.09e-06	0.0001	CcSEcCtD
Formoterol—Headache—Trandolapril—hypertension	8.08e-06	0.0001	CcSEcCtD
Formoterol—Vomiting—Telmisartan—hypertension	8.05e-06	9.99e-05	CcSEcCtD
Formoterol—Asthenia—Losartan—hypertension	8.05e-06	9.98e-05	CcSEcCtD
Formoterol—Headache—Enalapril—hypertension	8.04e-06	9.98e-05	CcSEcCtD
Formoterol—Pain—Timolol—hypertension	8.04e-06	9.97e-05	CcSEcCtD
Formoterol—Rash—Telmisartan—hypertension	7.99e-06	9.91e-05	CcSEcCtD
Formoterol—Dermatitis—Telmisartan—hypertension	7.98e-06	9.9e-05	CcSEcCtD
Formoterol—Diarrhoea—Furosemide—hypertension	7.95e-06	9.87e-05	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Lisinopril—hypertension	7.95e-06	9.86e-05	CcSEcCtD
Formoterol—Pruritus—Losartan—hypertension	7.93e-06	9.84e-05	CcSEcCtD
Formoterol—Headache—Telmisartan—hypertension	7.93e-06	9.84e-05	CcSEcCtD
Formoterol—Feeling abnormal—Ramipril—hypertension	7.92e-06	9.83e-05	CcSEcCtD
Formoterol—Dizziness—Perindopril—hypertension	7.91e-06	9.81e-05	CcSEcCtD
Formoterol—Insomnia—Lisinopril—hypertension	7.89e-06	9.79e-05	CcSEcCtD
Formoterol—Dizziness—Irbesartan—hypertension	7.88e-06	9.78e-05	CcSEcCtD
Formoterol—Diarrhoea—Betaxolol—hypertension	7.87e-06	9.77e-05	CcSEcCtD
Formoterol—Gastrointestinal pain—Ramipril—hypertension	7.86e-06	9.76e-05	CcSEcCtD
Formoterol—Nausea—Clonidine—hypertension	7.85e-06	9.74e-05	CcSEcCtD
Formoterol—Vomiting—Captopril—hypertension	7.83e-06	9.71e-05	CcSEcCtD
Formoterol—Dizziness—Hydrochlorothiazide—hypertension	7.82e-06	9.7e-05	CcSEcCtD
Formoterol—Dyspnoea—Lisinopril—hypertension	7.78e-06	9.65e-05	CcSEcCtD
Formoterol—Rash—Captopril—hypertension	7.77e-06	9.63e-05	CcSEcCtD
Formoterol—Dermatitis—Captopril—hypertension	7.76e-06	9.62e-05	CcSEcCtD
Formoterol—Somnolence—Lisinopril—hypertension	7.75e-06	9.62e-05	CcSEcCtD
Formoterol—Feeling abnormal—Timolol—hypertension	7.75e-06	9.61e-05	CcSEcCtD
Formoterol—Headache—Captopril—hypertension	7.72e-06	9.57e-05	CcSEcCtD
Formoterol—Gastrointestinal pain—Timolol—hypertension	7.69e-06	9.54e-05	CcSEcCtD
Formoterol—Dizziness—Furosemide—hypertension	7.69e-06	9.54e-05	CcSEcCtD
Formoterol—Dyspepsia—Lisinopril—hypertension	7.68e-06	9.52e-05	CcSEcCtD
Formoterol—Diarrhoea—Losartan—hypertension	7.67e-06	9.52e-05	CcSEcCtD
Formoterol—Nausea—Trandolapril—hypertension	7.66e-06	9.5e-05	CcSEcCtD
Formoterol—Urticaria—Ramipril—hypertension	7.64e-06	9.48e-05	CcSEcCtD
Formoterol—Nausea—Enalapril—hypertension	7.63e-06	9.46e-05	CcSEcCtD
Formoterol—Dizziness—Betaxolol—hypertension	7.61e-06	9.44e-05	CcSEcCtD
Formoterol—Vomiting—Perindopril—hypertension	7.6e-06	9.43e-05	CcSEcCtD
Formoterol—Body temperature increased—Ramipril—hypertension	7.6e-06	9.43e-05	CcSEcCtD
Formoterol—Abdominal pain—Ramipril—hypertension	7.6e-06	9.43e-05	CcSEcCtD
Formoterol—Vomiting—Irbesartan—hypertension	7.58e-06	9.4e-05	CcSEcCtD
Formoterol—Rash—Perindopril—hypertension	7.54e-06	9.35e-05	CcSEcCtD
Formoterol—Dermatitis—Perindopril—hypertension	7.53e-06	9.35e-05	CcSEcCtD
Formoterol—Gastrointestinal disorder—Lisinopril—hypertension	7.53e-06	9.34e-05	CcSEcCtD
Formoterol—Nausea—Telmisartan—hypertension	7.52e-06	9.33e-05	CcSEcCtD
Formoterol—Fatigue—Lisinopril—hypertension	7.52e-06	9.33e-05	CcSEcCtD
Formoterol—Vomiting—Hydrochlorothiazide—hypertension	7.52e-06	9.32e-05	CcSEcCtD
Formoterol—Rash—Irbesartan—hypertension	7.51e-06	9.32e-05	CcSEcCtD
Formoterol—Dermatitis—Irbesartan—hypertension	7.51e-06	9.31e-05	CcSEcCtD
Formoterol—Headache—Perindopril—hypertension	7.49e-06	9.29e-05	CcSEcCtD
Formoterol—Urticaria—Timolol—hypertension	7.47e-06	9.27e-05	CcSEcCtD
Formoterol—Headache—Irbesartan—hypertension	7.47e-06	9.26e-05	CcSEcCtD
Formoterol—Pain—Lisinopril—hypertension	7.46e-06	9.25e-05	CcSEcCtD
Formoterol—Constipation—Lisinopril—hypertension	7.46e-06	9.25e-05	CcSEcCtD
Formoterol—Rash—Hydrochlorothiazide—hypertension	7.45e-06	9.25e-05	CcSEcCtD
Formoterol—Dermatitis—Hydrochlorothiazide—hypertension	7.45e-06	9.24e-05	CcSEcCtD
Formoterol—Body temperature increased—Timolol—hypertension	7.43e-06	9.22e-05	CcSEcCtD
Formoterol—Abdominal pain—Timolol—hypertension	7.43e-06	9.22e-05	CcSEcCtD
Formoterol—Dizziness—Losartan—hypertension	7.42e-06	9.2e-05	CcSEcCtD
Formoterol—Headache—Hydrochlorothiazide—hypertension	7.4e-06	9.19e-05	CcSEcCtD
Formoterol—Vomiting—Furosemide—hypertension	7.39e-06	9.17e-05	CcSEcCtD
Formoterol—Rash—Furosemide—hypertension	7.33e-06	9.09e-05	CcSEcCtD
Formoterol—Dermatitis—Furosemide—hypertension	7.32e-06	9.08e-05	CcSEcCtD
Formoterol—Vomiting—Betaxolol—hypertension	7.32e-06	9.08e-05	CcSEcCtD
Formoterol—Nausea—Captopril—hypertension	7.32e-06	9.08e-05	CcSEcCtD
Formoterol—Headache—Furosemide—hypertension	7.28e-06	9.03e-05	CcSEcCtD
Formoterol—Rash—Betaxolol—hypertension	7.26e-06	9e-05	CcSEcCtD
Formoterol—Dermatitis—Betaxolol—hypertension	7.25e-06	8.99e-05	CcSEcCtD
Formoterol—Headache—Betaxolol—hypertension	7.21e-06	8.94e-05	CcSEcCtD
Formoterol—Feeling abnormal—Lisinopril—hypertension	7.19e-06	8.92e-05	CcSEcCtD
Formoterol—Gastrointestinal pain—Lisinopril—hypertension	7.13e-06	8.85e-05	CcSEcCtD
Formoterol—Vomiting—Losartan—hypertension	7.13e-06	8.85e-05	CcSEcCtD
Formoterol—Nausea—Perindopril—hypertension	7.1e-06	8.81e-05	CcSEcCtD
Formoterol—Hypersensitivity—Ramipril—hypertension	7.09e-06	8.79e-05	CcSEcCtD
Formoterol—Nausea—Irbesartan—hypertension	7.08e-06	8.78e-05	CcSEcCtD
Formoterol—Rash—Losartan—hypertension	7.07e-06	8.77e-05	CcSEcCtD
Formoterol—Dermatitis—Losartan—hypertension	7.06e-06	8.77e-05	CcSEcCtD
Formoterol—Headache—Losartan—hypertension	7.03e-06	8.72e-05	CcSEcCtD
Formoterol—Nausea—Hydrochlorothiazide—hypertension	7.02e-06	8.71e-05	CcSEcCtD
Formoterol—Urticaria—Lisinopril—hypertension	6.93e-06	8.6e-05	CcSEcCtD
Formoterol—Hypersensitivity—Timolol—hypertension	6.93e-06	8.59e-05	CcSEcCtD
Formoterol—Nausea—Furosemide—hypertension	6.9e-06	8.57e-05	CcSEcCtD
Formoterol—Asthenia—Ramipril—hypertension	6.9e-06	8.56e-05	CcSEcCtD
Formoterol—Body temperature increased—Lisinopril—hypertension	6.89e-06	8.55e-05	CcSEcCtD
Formoterol—Abdominal pain—Lisinopril—hypertension	6.89e-06	8.55e-05	CcSEcCtD
Formoterol—Nausea—Betaxolol—hypertension	6.84e-06	8.48e-05	CcSEcCtD
Formoterol—Pruritus—Ramipril—hypertension	6.8e-06	8.44e-05	CcSEcCtD
Formoterol—Asthenia—Timolol—hypertension	6.75e-06	8.37e-05	CcSEcCtD
Formoterol—Nausea—Losartan—hypertension	6.66e-06	8.27e-05	CcSEcCtD
Formoterol—Pruritus—Timolol—hypertension	6.65e-06	8.25e-05	CcSEcCtD
Formoterol—Diarrhoea—Ramipril—hypertension	6.58e-06	8.16e-05	CcSEcCtD
Formoterol—Diarrhoea—Timolol—hypertension	6.43e-06	7.98e-05	CcSEcCtD
Formoterol—Hypersensitivity—Lisinopril—hypertension	6.43e-06	7.97e-05	CcSEcCtD
Formoterol—Dizziness—Ramipril—hypertension	6.36e-06	7.89e-05	CcSEcCtD
Formoterol—Asthenia—Lisinopril—hypertension	6.26e-06	7.76e-05	CcSEcCtD
Formoterol—Dizziness—Timolol—hypertension	6.22e-06	7.71e-05	CcSEcCtD
Formoterol—Pruritus—Lisinopril—hypertension	6.17e-06	7.66e-05	CcSEcCtD
Formoterol—Vomiting—Ramipril—hypertension	6.11e-06	7.59e-05	CcSEcCtD
Formoterol—Rash—Ramipril—hypertension	6.06e-06	7.52e-05	CcSEcCtD
Formoterol—Dermatitis—Ramipril—hypertension	6.06e-06	7.52e-05	CcSEcCtD
Formoterol—Headache—Ramipril—hypertension	6.02e-06	7.47e-05	CcSEcCtD
Formoterol—Vomiting—Timolol—hypertension	5.98e-06	7.42e-05	CcSEcCtD
Formoterol—Diarrhoea—Lisinopril—hypertension	5.97e-06	7.4e-05	CcSEcCtD
Formoterol—Rash—Timolol—hypertension	5.93e-06	7.35e-05	CcSEcCtD
Formoterol—Dermatitis—Timolol—hypertension	5.92e-06	7.35e-05	CcSEcCtD
Formoterol—Headache—Timolol—hypertension	5.89e-06	7.31e-05	CcSEcCtD
Formoterol—Dizziness—Lisinopril—hypertension	5.77e-06	7.16e-05	CcSEcCtD
Formoterol—Nausea—Ramipril—hypertension	5.71e-06	7.09e-05	CcSEcCtD
Formoterol—Nausea—Timolol—hypertension	5.58e-06	6.93e-05	CcSEcCtD
Formoterol—Vomiting—Lisinopril—hypertension	5.55e-06	6.88e-05	CcSEcCtD
Formoterol—Rash—Lisinopril—hypertension	5.5e-06	6.82e-05	CcSEcCtD
Formoterol—Dermatitis—Lisinopril—hypertension	5.49e-06	6.82e-05	CcSEcCtD
Formoterol—Headache—Lisinopril—hypertension	5.46e-06	6.78e-05	CcSEcCtD
Formoterol—Nausea—Lisinopril—hypertension	5.18e-06	6.43e-05	CcSEcCtD
Formoterol—CYP2C9—Metabolism—CETP—hypertension	1.58e-06	4.43e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—HMGCR—hypertension	1.56e-06	4.39e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GOT2—hypertension	1.56e-06	4.39e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR2A—hypertension	1.55e-06	4.35e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PRKCD—hypertension	1.55e-06	4.34e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCR5—hypertension	1.55e-06	4.34e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—C3—hypertension	1.55e-06	4.34e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	1.54e-06	4.33e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—AGT—hypertension	1.54e-06	4.31e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ADRA2A—hypertension	1.53e-06	4.3e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP17A1—hypertension	1.52e-06	4.27e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR2A—hypertension	1.52e-06	4.25e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—C3—hypertension	1.51e-06	4.24e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP17A1—hypertension	1.51e-06	4.24e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CALM1—hypertension	1.51e-06	4.24e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTGS1—hypertension	1.51e-06	4.23e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ENO1—hypertension	1.51e-06	4.23e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PDGFB—hypertension	1.51e-06	4.22e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—APOE—hypertension	1.5e-06	4.22e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—FGFR1—hypertension	1.5e-06	4.2e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTGS1—hypertension	1.5e-06	4.2e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ENO1—hypertension	1.5e-06	4.2e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CAV1—hypertension	1.49e-06	4.18e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—APOA1—hypertension	1.49e-06	4.17e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HIF1A—hypertension	1.48e-06	4.14e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PDGFB—hypertension	1.47e-06	4.13e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hypertension	1.47e-06	4.13e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AGT—hypertension	1.47e-06	4.12e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—FGFR1—hypertension	1.47e-06	4.11e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CTGF—hypertension	1.45e-06	4.07e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CALM1—hypertension	1.45e-06	4.05e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HIF1A—hypertension	1.44e-06	4.05e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APOE—hypertension	1.44e-06	4.04e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—LEP—hypertension	1.44e-06	4.04e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CTGF—hypertension	1.44e-06	4.04e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—HMGCR—hypertension	1.44e-06	4.04e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GOT2—hypertension	1.44e-06	4.04e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AGT—hypertension	1.44e-06	4.03e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—TH—hypertension	1.43e-06	4.02e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CALM2—hypertension	1.43e-06	4.01e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CAV1—hypertension	1.43e-06	4e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—HMGCR—hypertension	1.43e-06	4e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GOT2—hypertension	1.43e-06	4e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APOA1—hypertension	1.42e-06	3.99e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CALM1—hypertension	1.41e-06	3.97e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—hypertension	1.41e-06	3.96e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—KDR—hypertension	1.41e-06	3.96e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—LEP—hypertension	1.41e-06	3.95e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APOE—hypertension	1.41e-06	3.95e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ADRA2A—hypertension	1.41e-06	3.95e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	1.41e-06	3.95e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ADRA2A—hypertension	1.4e-06	3.92e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CAV1—hypertension	1.4e-06	3.92e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GCG—hypertension	1.39e-06	3.91e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—SLC2A4—hypertension	1.39e-06	3.91e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APOA1—hypertension	1.39e-06	3.91e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—KDR—hypertension	1.38e-06	3.87e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PRKCB—hypertension	1.36e-06	3.81e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—F2—hypertension	1.36e-06	3.81e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—FN1—hypertension	1.36e-06	3.81e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GOT1—hypertension	1.35e-06	3.79e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NOTCH1—hypertension	1.33e-06	3.73e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—F2—hypertension	1.33e-06	3.73e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—FN1—hypertension	1.33e-06	3.73e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PRKCB—hypertension	1.33e-06	3.73e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—TH—hypertension	1.32e-06	3.7e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CALM2—hypertension	1.31e-06	3.69e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—STK11—hypertension	1.31e-06	3.68e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP19A1—hypertension	1.31e-06	3.68e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PPARG—hypertension	1.31e-06	3.68e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—TH—hypertension	1.31e-06	3.67e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CALM2—hypertension	1.3e-06	3.65e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NOTCH1—hypertension	1.3e-06	3.65e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—POMC—hypertension	1.29e-06	3.63e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—hypertension	1.29e-06	3.61e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—INS—hypertension	1.29e-06	3.61e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SLC2A4—hypertension	1.28e-06	3.6e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GCG—hypertension	1.28e-06	3.6e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SLC2A4—hypertension	1.27e-06	3.57e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GCG—hypertension	1.27e-06	3.57e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GOT1—hypertension	1.24e-06	3.48e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—POMC—hypertension	1.24e-06	3.47e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GOT1—hypertension	1.23e-06	3.45e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hypertension	1.23e-06	3.45e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—INS—hypertension	1.23e-06	3.45e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—COMT—hypertension	1.22e-06	3.42e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCL2—hypertension	1.21e-06	3.4e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—POMC—hypertension	1.21e-06	3.39e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—STK11—hypertension	1.21e-06	3.38e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP19A1—hypertension	1.21e-06	3.38e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—INS—hypertension	1.2e-06	3.38e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GNB3—hypertension	1.2e-06	3.37e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPARGC1A—hypertension	1.2e-06	3.37e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—HMOX1—hypertension	1.2e-06	3.36e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—STK11—hypertension	1.2e-06	3.35e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP19A1—hypertension	1.2e-06	3.35e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IGF1—hypertension	1.19e-06	3.34e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AKT2—hypertension	1.19e-06	3.34e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—EGFR—hypertension	1.18e-06	3.32e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCL2—hypertension	1.18e-06	3.32e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CAT—hypertension	1.18e-06	3.31e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ALB—hypertension	1.18e-06	3.31e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hypertension	1.17e-06	3.29e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GNAS—hypertension	1.17e-06	3.28e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IGF1—hypertension	1.16e-06	3.27e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AKT2—hypertension	1.16e-06	3.26e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—EGFR—hypertension	1.16e-06	3.25e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOB—hypertension	1.15e-06	3.22e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SERPINE1—hypertension	1.13e-06	3.17e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PIK3R1—hypertension	1.13e-06	3.16e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—NOS3—hypertension	1.13e-06	3.16e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hypertension	1.12e-06	3.15e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—COMT—hypertension	1.12e-06	3.15e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTM1—hypertension	1.12e-06	3.13e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—COMT—hypertension	1.11e-06	3.12e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GNB3—hypertension	1.11e-06	3.1e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPARGC1A—hypertension	1.11e-06	3.1e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SERPINE1—hypertension	1.11e-06	3.1e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—HMOX1—hypertension	1.1e-06	3.09e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPARGC1A—hypertension	1.1e-06	3.07e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GNB3—hypertension	1.1e-06	3.07e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—LPL—hypertension	1.09e-06	3.07e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—FGF2—hypertension	1.09e-06	3.07e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—HMOX1—hypertension	1.09e-06	3.06e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—RHOA—hypertension	1.09e-06	3.06e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CAT—hypertension	1.09e-06	3.05e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PIK3R1—hypertension	1.08e-06	3.03e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NOS3—hypertension	1.08e-06	3.03e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CAT—hypertension	1.08e-06	3.02e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GNAS—hypertension	1.08e-06	3.02e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ADCY5—hypertension	1.07e-06	3.01e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hypertension	1.07e-06	3e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—FGF2—hypertension	1.07e-06	3e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GPX1—hypertension	1.07e-06	3e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GNAS—hypertension	1.07e-06	2.99e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—RHOA—hypertension	1.07e-06	2.99e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PRKCA—hypertension	1.06e-06	2.96e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP1A1—hypertension	1.06e-06	2.96e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PIK3R1—hypertension	1.06e-06	2.96e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NOS3—hypertension	1.06e-06	2.96e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOB—hypertension	1.05e-06	2.96e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOB—hypertension	1.05e-06	2.93e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CD36—hypertension	1.04e-06	2.92e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PTGS2—hypertension	1.03e-06	2.89e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTM1—hypertension	1.03e-06	2.88e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTM1—hypertension	1.02e-06	2.85e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—RELA—hypertension	1.02e-06	2.85e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—LPL—hypertension	1.01e-06	2.82e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—LPL—hypertension	9.98e-07	2.8e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MTOR—hypertension	9.96e-07	2.79e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—RELA—hypertension	9.94e-07	2.79e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ADCY5—hypertension	9.86e-07	2.76e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MTHFR—hypertension	9.86e-07	2.76e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GPX1—hypertension	9.82e-07	2.75e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ADCY5—hypertension	9.77e-07	2.74e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MTOR—hypertension	9.74e-07	2.73e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GPX1—hypertension	9.74e-07	2.73e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PRKCA—hypertension	9.72e-07	2.73e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP1A1—hypertension	9.72e-07	2.73e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPARA—hypertension	9.67e-07	2.71e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PRKCA—hypertension	9.64e-07	2.7e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP1A1—hypertension	9.64e-07	2.7e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CXCL8—hypertension	9.57e-07	2.68e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CD36—hypertension	9.57e-07	2.68e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CD36—hypertension	9.48e-07	2.66e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—AGT—hypertension	9.36e-07	2.63e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CXCL8—hypertension	9.36e-07	2.63e-05	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—AKT1—hypertension	9.25e-07	2.59e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CALM1—hypertension	9.21e-07	2.58e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOE—hypertension	9.17e-07	2.57e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—IL6—hypertension	9.1e-07	2.55e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CAV1—hypertension	9.09e-07	2.55e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOA1—hypertension	9.07e-07	2.54e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MTHFR—hypertension	9.06e-07	2.54e-05	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—AKT1—hypertension	9.05e-07	2.54e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PTEN—hypertension	8.99e-07	2.52e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MTHFR—hypertension	8.99e-07	2.52e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—IL6—hypertension	8.9e-07	2.5e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPARA—hypertension	8.89e-07	2.49e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPARA—hypertension	8.82e-07	2.47e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MMP9—hypertension	8.66e-07	2.43e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CDKN1A—hypertension	8.63e-07	2.42e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—AGT—hypertension	8.61e-07	2.42e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PTEN—hypertension	8.61e-07	2.41e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—EP300—hypertension	8.58e-07	2.41e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—AGT—hypertension	8.54e-07	2.39e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MMP9—hypertension	8.47e-07	2.38e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CALM1—hypertension	8.47e-07	2.38e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CDKN1A—hypertension	8.44e-07	2.37e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOE—hypertension	8.44e-07	2.37e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MAPK8—hypertension	8.42e-07	2.36e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PTEN—hypertension	8.42e-07	2.36e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—AKT1—hypertension	8.4e-07	2.36e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CALM1—hypertension	8.4e-07	2.35e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOE—hypertension	8.37e-07	2.35e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CAV1—hypertension	8.36e-07	2.34e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOA1—hypertension	8.34e-07	2.34e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CAV1—hypertension	8.29e-07	2.32e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOA1—hypertension	8.27e-07	2.32e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MAPK8—hypertension	8.24e-07	2.31e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—AKT1—hypertension	8.21e-07	2.3e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EP300—hypertension	8.21e-07	2.3e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EP300—hypertension	8.03e-07	2.25e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPARG—hypertension	7.99e-07	2.24e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SRC—hypertension	7.98e-07	2.24e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—POMC—hypertension	7.88e-07	2.21e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—INS—hypertension	7.84e-07	2.2e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SRC—hypertension	7.81e-07	2.19e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—VEGFA—hypertension	7.77e-07	2.18e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—VEGFA—hypertension	7.6e-07	2.13e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPARG—hypertension	7.35e-07	2.06e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPARG—hypertension	7.29e-07	2.04e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—POMC—hypertension	7.25e-07	2.03e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—INS—hypertension	7.21e-07	2.02e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—POMC—hypertension	7.19e-07	2.02e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ALB—hypertension	7.19e-07	2.02e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MYC—hypertension	7.15e-07	2.01e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—INS—hypertension	7.15e-07	2e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TGFB1—hypertension	7.14e-07	2e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MYC—hypertension	7e-07	1.96e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EGFR—hypertension	7e-07	1.96e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TGFB1—hypertension	6.98e-07	1.96e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PIK3R1—hypertension	6.87e-07	1.93e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NOS3—hypertension	6.87e-07	1.93e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EGFR—hypertension	6.84e-07	1.92e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALB—hypertension	6.61e-07	1.85e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALB—hypertension	6.55e-07	1.84e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NOS3—hypertension	6.32e-07	1.77e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PIK3R1—hypertension	6.32e-07	1.77e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTGS2—hypertension	6.29e-07	1.76e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NOS3—hypertension	6.27e-07	1.76e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PIK3R1—hypertension	6.27e-07	1.76e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TP53—hypertension	5.87e-07	1.65e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTGS2—hypertension	5.78e-07	1.62e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TP53—hypertension	5.75e-07	1.61e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTGS2—hypertension	5.73e-07	1.61e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTEN—hypertension	5.48e-07	1.54e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL6—hypertension	5.38e-07	1.51e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL6—hypertension	5.26e-07	1.48e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—EP300—hypertension	5.23e-07	1.47e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—AKT1—hypertension	5.18e-07	1.45e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTEN—hypertension	5.04e-07	1.41e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTEN—hypertension	5e-07	1.4e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AKT1—hypertension	4.96e-07	1.39e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AKT1—hypertension	4.85e-07	1.36e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—EP300—hypertension	4.81e-07	1.35e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—EP300—hypertension	4.77e-07	1.34e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—AKT1—hypertension	3.16e-07	8.86e-06	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—AKT1—hypertension	2.91e-07	8.15e-06	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—AKT1—hypertension	2.88e-07	8.08e-06	CbGpPWpGaD
